This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moore, B. R.
Right arrow Articles by Ilett, K. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moore, B. R.
Right arrow Articles by Ilett, K. F.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, January 2008, p. 306-311, Vol. 52, No. 1
0066-4804/08/$08.00+0     doi:10.1128/AAC.00878-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Pharmacokinetics and Pharmacodynamics of Piperaquine in a Murine Malaria Model{triangledown}

Brioni R. Moore,1 Kevin T. Batty,1* Christopher Andrzejewski,1 Jeffrey D. Jago,2 Madhu Page-Sharp,3 and Kenneth F. Ilett3,4

School of Pharmacy, Curtin University of Technology, Bentley,1 School of Biomedical Sciences, Curtin University of Technology, Bentley,2 School of Medicine and Pharmacology, University of Western Australia, Crawley,3 Clinical Pharmacology & Toxicology Laboratory, Path West Laboratory Medicine, Nedlands, Western Australia, Australia4

Received 5 July 2007/ Returned for modification 9 September 2007/ Accepted 28 October 2007

Piperaquine (PQ) is an important partner in antimalarial treatment strategies. However, there is a paucity of detailed preclinical and pharmacokinetic data to link PQ serum concentrations and toxicity or efficacy. The aim of this study was to investigate the pharmacokinetics and pharmacodynamics of PQ in a murine malaria treatment model. The study comprised three arms. (i) PQ pharmacokinetic parameters were determined in healthy and malaria-infected mice (90 mg/kg PQ phosphate [PQP]). (ii) For determination of single-dose pharmacodynamics, Swiss mice were inoculated with Plasmodium berghei parasites and given PQP (10, 30, or 90 mg/kg intraperitoneally) at 2 to 5% starting parasitemia. After 60 days, the 90-mg/kg PQP group was reinoculated with P. berghei. (iii) Combination efficacy was investigated at doses of 10 mg/kg PQP and 30 mg/kg dihydroartemisinin (DHA). The median survival times were 4, 10, and 54 days for 0, 10, and 30 mg/kg PQP, respectively. All mice given 90 mg/kg PQP survived beyond 60 days, with a mean parasitemia of <1% before and after reinoculation. The nadir for DHA plus PQP was significantly lower (22-fold ± 12-fold) than the initial parasitemia for the individual drugs (DHA, 12-fold ± 5-fold; PQP, 13-fold ± 3-fold; P = 0.007 [analysis of variance]). The elimination half-lives of PQ in healthy and infected mice were 18 and 16 days, respectively, and the extrapolated residual PQ concentration at 60 days (<10 µg/liter) was ineffective at suppressing P. berghei infection. PQ has a potent antimalarial effect after single-dose treatment, and its efficacy was enhanced by combination with DHA.

* Corresponding author. Mailing address: School of Pharmacy, Curtin University of Technology, GPO Box U1987, Perth, Western Australia 6845, Australia. Phone: (61-8) 9266 7369. Fax: (61-8) 9266 2769. E-mail: Kevin.Batty{at}curtin.edu.au

{triangledown} Published ahead of print on 5 November 2007.

Antimicrobial Agents and Chemotherapy, January 2008, p. 306-311, Vol. 52, No. 1
0066-4804/08/$08.00+0     doi:10.1128/AAC.00878-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Moore, B. R., Ilett, K. F., Page-Sharp, M., Jago, J. D., Batty, K. T. (2009). Piperaquine Pharmacodynamics and Parasite Viability in a Murine Malaria Model. Antimicrob. Agents Chemother. 53: 2707-2713 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»